A multicenter postmarketing study to evaluate the placental transfer of certolizumab pegol in pregnant women receiving treatment with Cimzia® (certolizumab pegol) (CRIB) First published 07/01/2014 Last updated 31/03/2024 EU PAS number:EUPAS5507 Study Finalised